CLOSED: Effects of PF-03893787 on airway responses in asthmatic

• Research type

  Research Study

• Full title

  A randomised, double-blind (3rd Party open), double-dummy, placebo-and active controlled, 3-way crossover study to determine the effects of the oral PF-03893787 on allergen-induced airway responses in mild asthmatic subjects.

• IRAS ID

  17593

• Sponsor organisation

  Pfizer Global Research and Development

• Eudract number

  2009-009179-36

• ISRCTN Number

  n.a

• Clinicaltrials.gov Identifier

  n.a

• Research summary

  The aim of the study is to develop a drug that can be used for the treatment of asthma. The study will investigate the effects of the study drug (PF-03893787) and montelukast (positive control) on the early and late airway responses in mild asthmatic volunteers. The study will also look at the way in which the study drug is absorbed, metabolised and distributed through the body (pharmacokinetics), as well as its safety and tolerability.

• REC name

  East of England - Cambridge East Research Ethics Committee

• REC reference

  09/H0304/26

• Date of REC Opinion

  20 Apr 2009

• REC opinion

  Further Information Favourable Opinion